December A Big Month For OTCs
According to Kevin McPartland, a senior Tabb Group analyst, the full House of Representatives is expected to vote on its version of a derivative regulation bill by Dec. 15.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
